Agilent Technologies, Inc. Common Stock (A) stock analysis
A · Agilent Technologies, Inc. Common Stock
Latest recorded price: USD 173.02
Model-estimated fair value: USD 48.70. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Diagnostics & Research
At $173.02, A trades 255.3% above the model's base-case value of $48.70. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $38.36 in the conservative case and $60.07 in the optimistic case, with a valuation confidence score of 87/100. Fiscal 2025 figures: revenue growth 0.5%, free cash flow margin 16.6%, ROIC 12.8%. The model flags 1 risk signal for this company.
Similar companies in Healthcare
- Adaptive Biotechnologies Corporation (ADPT)
- CareDx, Inc. - Common Stock (CDNA)
- Charles River Laboratories International, Inc. (CRL)
- Castle Biosciences, Inc. (CSTL)
- Quest Diagnostics Incorporated Common Stock (DGX)
- Danaher Corporation Common Stock (DHR)
- Guardant Health, Inc. (GH)
- IDEXX Laboratories, Inc. - Common Stock (IDXX)